1. Home
  2. HMC vs ONC Comparison

HMC vs ONC Comparison

Compare HMC & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honda Motor Company Ltd.

HMC

Honda Motor Company Ltd.

N/A

Current Price

$26.04

Market Cap

41.2B

ML Signal

N/A

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$288.47

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HMC
ONC
Founded
1946
2010
Country
Japan
Switzerland
Employees
N/A
12000
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.2B
33.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HMC
ONC
Price
$26.04
$288.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
N/A
$386.70
AVG Volume (30 Days)
1.1M
226.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$759.19
Revenue Next Year
$4.76
$14.51
P/E Ratio
$40.40
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$24.56
$196.53
52 Week High
$34.89
$385.22

Technical Indicators

Market Signals
Indicator
HMC
ONC
Relative Strength Index (RSI) 27.02 31.25
Support Level N/A $234.09
Resistance Level $30.82 $306.61
Average True Range (ATR) 0.41 9.32
MACD -0.32 -4.24
Stochastic Oscillator 6.79 5.93

Price Performance

Historical Comparison
HMC
ONC

About HMC Honda Motor Company Ltd.

Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.7 million light vehicles and 20.6 million motorcycles in fiscal 2025, and consolidated sales were JPY 21.7 trillion. Automobiles constitute 65% of revenue and motorcycles 17%, with the rest split between power products and financial services. Honda also makes robots and private jets.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: